𝔖 Bobbio Scriptorium
✦   LIBER   ✦

More transgenic mouse models of dopamine deficiency

✍ Scribed by Beat Thöny; Nenad Blau

Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
75 KB
Volume
55
Category
Article
ISSN
0364-5134

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dopamine receptor agonists reverse behav
Dopamine receptor agonists reverse behavioral abnormalities of α-synuclein transgenic mouse, a new model of Parkinson's disease
✍ Masaki Wakamatsu; Shingo Iwata; Takeo Funakoshi; Makoto Yoshimoto 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 272 KB

## Abstract Parkinson's disease (PD) is characterized by loss of nigral dopaminergic (DAergic) neurons and presence of Lewy bodies, whose major component is α‐synuclein. We had previously generated transgenic mice termed __Syn130m__ that express truncated human α‐synuclein (amino acid residues 1–13

A transgenic mouse model of the slow-cha
A transgenic mouse model of the slow-channel syndrome
✍ Christopher M. Gomez; Bula B. Bhattacharyya; Pierre Charnet; John W. Day; Cesar 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 861 KB

To investigate the effect of acetylcholine receptor (AChR) mutations on neuromuscular transmission and to develop a model for the human neuromuscular disease, the slow-channel syndrome, we generated transgenic mice with abnormal AChRs using a 6 subunit with a mutation in the ion channel domain. In t

Mouse models of human single gene disord
Mouse models of human single gene disorders I: Non-transgenic mice
✍ Susan M. Darling; Catherine M. Abbott 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 980 KB

## Abstract Mouse models of human genetic disorders provide a valuable resource for investigating the pathogenesis of genetic disease and for testing potential therapies. The high degree of resolution of linkage mapping in the mouse allows mutant phenotypes to be mapped precisely which, combined wi